EV/EBITDA
-4.14
-0.37-9.81%
32 min ago
Summary
- As of March 10, 2025, KAPA EV/EBITDA is -4.14, with a fall of -0.37 (-9.81%) during the most recent trading day.
- KAPA EV/EBITDA is now -9.81% below its all-time high of -3.77.
Performance
KAPA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KAPA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -9.8% | +9.8% | +7.4% |
1 m1 month | +33.9% | -33.9% | -28.2% |
3 m3 months | +45.0% | -45.0% | -38.5% |
6 m6 months | - | - | - |
ytdytd | +39.0% | -39.0% | -32.9% |
1 y1 year | - | - | - |
5 y5 years | - | - | - |
KAPA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -9.8% | -6.47 | +36.0% | |
3 m | 3-month | -3.77 | -9.8% | -10.76 | +61.5% |
6 m | 6-month | -3.77 | -9.8% | -18.54 | +77.7% |
1 y | 1-year | -3.77 | -9.8% | -18.54 | +77.7% |
3 y | 3-year | -3.77 | -9.8% | -18.54 | +77.7% |
5 y | 5-year | -3.77 | -9.8% | -18.54 | +77.7% |
alltime | all time | -3.77 | -9.8% | -18.54 | +77.7% |
Kairos Pharma EV/EBITDA History
Date | Value |
---|---|
2025 | -4.14(-39.0%) |
Date | Value |
---|---|
2024 | -6.79 |
FAQ
- What is Kairos Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Kairos Pharma?
- What is KAPA EV/EBITDA year-to-date change?
What is Kairos Pharma EV/EBITDA?
The current EV/EBITDA of KAPA is -4.14
What is the all time high EV/EBITDA for Kairos Pharma?
Kairos Pharma all-time high EV/EBITDA is -3.77
What is KAPA EV/EBITDA year-to-date change?
Kairos Pharma EV/EBITDA has changed by +2.65 (+39.03%) since the beginning of the year